The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial

Jie Bai1,2,3, Bibo Wu1,2,3, Shasha Zhao1,2,3

  • 1Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, People's Republic of China.

Abstract

Insights

Programmed cell death protein 1 (PD-1) inhibitors combined with irradiation worsen radiation-induced myocardial injury. This combination increases high-mobility group box 1 (HMGB1)-associated inflammatory cytokines and cardiac damage.

Area of Science:

  • Cardiovascular research
  • Immunotherapy
  • Radiation oncology

Background:

  • Myocardial injury is a potential side effect of cancer therapies.
  • Programmed cell death protein 1 (PD-1) inhibitors are used in cancer treatment.
  • Irradiation is a common cancer treatment modality.

Purpose of the Study:

  • To investigate the combined effects of PD-1 inhibitors and irradiation on myocardial injury.
  • To analyze changes in high-mobility group box 1 (HMGB1)-associated inflammatory markers.

Main Methods:

  • A mouse model was used with four groups: control, PD-1 inhibitors alone, irradiation alone, and combined treatment.
  • Histopathological analysis (Hematoxylin-eosin, Masson staining) and apoptosis assessment (Tunel staining) were performed.
  • Flow cytometry, ELISA, Western blot, and qPCR were used to evaluate immune cell infiltration, inflammatory cytokines, and key protein/mRNA expression (HMGB1, TLR-4, NF-κB p65).

Main Results:

  • Combined PD-1 inhibitors and irradiation significantly increased myocardial injury, fibrosis, and apoptosis compared to control and monotherapy groups.
  • The combination therapy led to significantly higher levels of CD3+, CD8+ T lymphocytes, IL-1β, IL-6, and TNF-α in heart tissue.
  • Expression of HMGB1 and NF-κB p65 was elevated in all treatment groups, with a significant interaction observed between PD-1 inhibitors and irradiation, particularly for HMGB1 and CD8+ T lymphocytes.

Conclusions:

  • PD-1 inhibitors exacerbate radiation-induced myocardial injury.
  • The combination therapy increases HMGB1-associated inflammatory cytokines.
  • This study highlights the detrimental interaction between PD-1 inhibitors and irradiation on cardiac tissue.